{
  "main_header": {
    "sid": 408336,
    "name": "Transgene Biotek",
    "stock_name": "Transgene Biotek",
    "full_name": "Transgene Biotek Ltd",
    "name_url": "stocks-analysis/transgene-biotek",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.01",
    "chg": 0.01,
    "chgp": "0.33%",
    "dir": 1,
    "prev_price": "3.00",
    "mcapval": "22.81 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526139,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE773D01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "9.35 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transgene-biotek-408336-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3739454",
        "imagepath": "",
        "date": "2025-12-02 00:24:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Transgene Biotek’s stock has underperformed significantly against the broader market benchmarks. Over the past week, the share price has declined by 10.47%, while the Sensex has gained 0.87%. This divergence is even more pronounced over longer periods, with the stock down 9.52% in the last month compared to a 2.03% rise in the Sensex. Year-to-date, the stock has plummeted by nearly 50%, whereas the Sensex has advanced by 9.60%. Over the past year, the stock’s decline of 48.49% starkly contrasts with the Sensex’s 7.32% gain. Even over a three-year horizon, Transgene Biotek’s 18.34% return trails the Sensex’s 35.33%, and over five years, the stock has lost 30.77% while the benchmark surged 91.78%.</p>\n<p><strong>Technical Indicators S..."
      },
      {
        "title": "How has been the historical performance of Transgene Biotek?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-transgene-biotek-3702753",
        "imagepath": "",
        "date": "2025-11-14 23:31:50",
        "description": "Answer:\nThe historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years.\n\nBreakdown:\nTransge..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3686779",
        "imagepath": "",
        "date": "2025-11-10 21:20:52",
        "description": "As of 10-Nov, Transgene Biotek Ltd's stock price is currently at 3.84, reflecting an increase of 0.33 or 9.4%. The stock has shown a positive performance today, outperforming its sector by 10.98% and has been on a consecutive gain for the last two days, accumulating a total return of 13.27% during this period. However, despite this recent uptick, the stock has experienced a significant decline year-to-date of 43.78% and a 1-month drop of 7.69%. The stock's delivery volume has decreased by 2.05% compared to the 5-day average, indicating a falling investor participation, which may temper the positive momentum. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Transgene Biotek's short-term return of +1.05% over the past week contrasts with the Sensex, which has declined by 0.53% during ..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3676529",
        "imagepath": "",
        "date": "2025-11-06 21:16:53",
        "description": "As of 06-Nov, Transgene Biotek Ltd's stock price is currently at Rs 3.36, reflecting a decline of Rs 0.22 or 6.15%. The stock has been underperforming, having lost 11.58% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, it is 4.46% away from its 52-week low of Rs 3.21. In terms of performance relative to the benchmark, the stock has seen significant declines, with a year-to-date drop of 50.81%, while the Sensex has gained 6.62% during the same period. Although there has been a notable increase in investor participation, with delivery volume rising by 79.97% against the 5-day average, the overall sentiment remains negative.\n\nBroader Market Context: In the short term, Transgene Biotek's performance has been markedly worse than the Sensex, which has only declined by 1.30% over the past week, while Transgene Biotek has dropped by 10.16%. This stark c..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3671748",
        "imagepath": "",
        "date": "2025-11-04 21:24:13",
        "description": "As of 04-Nov, Transgene Biotek Ltd is experiencing a decline in its stock price, currently at 3.68, which represents a decrease of 0.12 or 3.16%. The stock has underperformed its sector today by 2.81% and has shown a trend reversal, falling after two consecutive days of gains. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also seen a significant drop in investor participation, with delivery volume falling by 55.3% against the 5-day average. Over the past week, the stock has declined by 11.96%, while it has fallen 12.17% over the past month, and it has a year-to-date decline of 46.12%.\n\nIn the broader market context, the Sensex has only declined by 1.38% over the past week, indicating that Transgene Biotek's performance is significantly worse than the overall market. While the benchmark has shown a positive return ..."
      },
      {
        "title": "When is the next results date for Transgene Biotek?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transgene-biotek-3668407",
        "imagepath": "",
        "date": "2025-11-03 23:17:07",
        "description": "Transgene Biotek is scheduled to declare its results on 14 November 2025...."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3662466",
        "imagepath": "",
        "date": "2025-10-31 21:21:47",
        "description": "As of 31-Oct, Transgene Biotek Ltd's stock price is currently at Rs. 3.78, reflecting an increase of Rs. 0.04 or 1.07%. The stock has recently shown signs of recovery after two consecutive days of decline, outperforming its sector by 2.34%. However, it has also hit a new 52-week low of Rs. 3.21 today. Despite this short-term gain, the stock has experienced significant declines over the past week, month, and year, with returns of -11.68%, -8.92%, and -46.00%, respectively, indicating a challenging performance relative to the benchmark Sensex, which has shown positive returns over the same periods. The stock is currently trading below all its moving averages, suggesting a bearish trend, although rising investor participation, with a delivery volume increase of 223.78%, indicates some renewed interest.\n\nIn the broader market context, while Transgene Biotek has seen a slight uptick today, its overall performanc..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3586582",
        "imagepath": "",
        "date": "2025-10-01 21:04:26",
        "description": "As of 01-October, Transgene Biotek Ltd's stock price is currently at 4.18, reflecting an increase of 0.22 or 5.56%. The stock has shown a trend reversal, gaining after two consecutive days of decline. It has outperformed its sector by 4.85% today, and the delivery volume has increased by 4.41% compared to the 5-day average, indicating rising investor participation. However, despite this positive movement, the stock's year-to-date performance remains significantly negative at -38.80%, and its one-year return is down by 45.00%. The stock is currently trading above its 5-day and 20-day moving averages but below its longer-term averages, which suggests mixed momentum.\n\nIn the broader market context, the Sensex has experienced a decline of 0.90% over the past week, while Transgene Biotek has gained 2.45% in the same period, indicating that the stock is performing well relative to the benchmark. Despite the recen..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3559828",
        "imagepath": "",
        "date": "2025-09-23 21:17:53",
        "description": "As of 23-Sep, Transgene Biotek Ltd's stock price is currently at 4.00, reflecting an increase of 0.05, or 1.27%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 4.17% during this period. However, it has underperformed over the longer term, with a year-to-date decline of 41.43% and a one-year drop of 50.06%. Additionally, the stock's delivery volume has significantly decreased by 95.73% compared to the five-day average, indicating falling investor participation. There are no specific positive or negative factors available to further explain the stock's recent movement.\n\nBroader market context shows that while Transgene Biotek has outperformed its sector by 1.74% today, it has still struggled in comparison to the benchmark Sensex, which has gained 5.07% year-to-date. Over the past week, the stock has declined by 5.44%, contrasting with the Sensex's minor dro..."
      }
    ],
    "total": 78,
    "sid": "408336",
    "stock_news_url": "https://www.marketsmojo.com/news/transgene-biotek-408336"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-Nov-2025",
      "details": "Newspaper Advertisement of financial results under regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2025.",
      "datetime": "14-Nov-2025",
      "details": "We wish to inform you that the Board of Directors of the Company at its meeting held on Friday November 14 2025 has considered and approved the following matters:",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. (Copy Enclosed)",
      "datetime": "14-Nov-2025",
      "details": "Un-Audited Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Transgene Biotek falling/rising?

2025-12-02 00:24:46

Recent Price Movement and Market Comparison

Transgene Biotek’s stock has underperformed significantly against the broader market benchmarks. Over the past week, the share price has declined by 10.47%, while the Sensex has gained 0.87%. This divergence is even more pronounced over longer periods, with the stock down 9.52% in the last month compared to a 2.03% rise in the Sensex. Year-to-date, the stock has plummeted by nearly 50%, whereas the Sensex has advanced by 9.60%. Over the past year, the stock’s decline of 48.49% starkly contrasts with the Sensex’s 7.32% gain. Even over a three-year horizon, Transgene Biotek’s 18.34% return trails the Sensex’s 35.33%, and over five years, the stock has lost 30.77% while the benchmark surged 91.78%.

Technical Indicators S...

Read More

How has been the historical performance of Transgene Biotek?

2025-11-14 23:31:50

Answer: The historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years. Breakdown: Transge...

Read More

Why is Transgene Biotek falling/rising?

2025-11-10 21:20:52

As of 10-Nov, Transgene Biotek Ltd's stock price is currently at 3.84, reflecting an increase of 0.33 or 9.4%. The stock has shown a positive performance today, outperforming its sector by 10.98% and has been on a consecutive gain for the last two days, accumulating a total return of 13.27% during this period. However, despite this recent uptick, the stock has experienced a significant decline year-to-date of 43.78% and a 1-month drop of 7.69%. The stock's delivery volume has decreased by 2.05% compared to the 5-day average, indicating a falling investor participation, which may temper the positive momentum. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Transgene Biotek's short-term return of +1.05% over the past week contrasts with the Sensex, which has declined by 0.53% during ...

Read More

Why is Transgene Biotek falling/rising?

2025-11-06 21:16:53

As of 06-Nov, Transgene Biotek Ltd's stock price is currently at Rs 3.36, reflecting a decline of Rs 0.22 or 6.15%. The stock has been underperforming, having lost 11.58% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, it is 4.46% away from its 52-week low of Rs 3.21. In terms of performance relative to the benchmark, the stock has seen significant declines, with a year-to-date drop of 50.81%, while the Sensex has gained 6.62% during the same period. Although there has been a notable increase in investor participation, with delivery volume rising by 79.97% against the 5-day average, the overall sentiment remains negative. Broader Market Context: In the short term, Transgene Biotek's performance has been markedly worse than the Sensex, which has only declined by 1.30% over the past week, while Transgene Biotek has dropped by 10.16%. This stark c...

Read More

Why is Transgene Biotek falling/rising?

2025-11-04 21:24:13

As of 04-Nov, Transgene Biotek Ltd is experiencing a decline in its stock price, currently at 3.68, which represents a decrease of 0.12 or 3.16%. The stock has underperformed its sector today by 2.81% and has shown a trend reversal, falling after two consecutive days of gains. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also seen a significant drop in investor participation, with delivery volume falling by 55.3% against the 5-day average. Over the past week, the stock has declined by 11.96%, while it has fallen 12.17% over the past month, and it has a year-to-date decline of 46.12%. In the broader market context, the Sensex has only declined by 1.38% over the past week, indicating that Transgene Biotek's performance is significantly worse than the overall market. While the benchmark has shown a positive return ...

Read More

When is the next results date for Transgene Biotek?

2025-11-03 23:17:07

Transgene Biotek is scheduled to declare its results on 14 November 2025....

Read More

Why is Transgene Biotek falling/rising?

2025-10-31 21:21:47

As of 31-Oct, Transgene Biotek Ltd's stock price is currently at Rs. 3.78, reflecting an increase of Rs. 0.04 or 1.07%. The stock has recently shown signs of recovery after two consecutive days of decline, outperforming its sector by 2.34%. However, it has also hit a new 52-week low of Rs. 3.21 today. Despite this short-term gain, the stock has experienced significant declines over the past week, month, and year, with returns of -11.68%, -8.92%, and -46.00%, respectively, indicating a challenging performance relative to the benchmark Sensex, which has shown positive returns over the same periods. The stock is currently trading below all its moving averages, suggesting a bearish trend, although rising investor participation, with a delivery volume increase of 223.78%, indicates some renewed interest. In the broader market context, while Transgene Biotek has seen a slight uptick today, its overall performanc...

Read More

Why is Transgene Biotek falling/rising?

2025-10-01 21:04:26

As of 01-October, Transgene Biotek Ltd's stock price is currently at 4.18, reflecting an increase of 0.22 or 5.56%. The stock has shown a trend reversal, gaining after two consecutive days of decline. It has outperformed its sector by 4.85% today, and the delivery volume has increased by 4.41% compared to the 5-day average, indicating rising investor participation. However, despite this positive movement, the stock's year-to-date performance remains significantly negative at -38.80%, and its one-year return is down by 45.00%. The stock is currently trading above its 5-day and 20-day moving averages but below its longer-term averages, which suggests mixed momentum. In the broader market context, the Sensex has experienced a decline of 0.90% over the past week, while Transgene Biotek has gained 2.45% in the same period, indicating that the stock is performing well relative to the benchmark. Despite the recen...

Read More

Why is Transgene Biotek falling/rising?

2025-09-23 21:17:53

As of 23-Sep, Transgene Biotek Ltd's stock price is currently at 4.00, reflecting an increase of 0.05, or 1.27%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 4.17% during this period. However, it has underperformed over the longer term, with a year-to-date decline of 41.43% and a one-year drop of 50.06%. Additionally, the stock's delivery volume has significantly decreased by 95.73% compared to the five-day average, indicating falling investor participation. There are no specific positive or negative factors available to further explain the stock's recent movement. Broader market context shows that while Transgene Biotek has outperformed its sector by 1.74% today, it has still struggled in comparison to the benchmark Sensex, which has gained 5.07% year-to-date. Over the past week, the stock has declined by 5.44%, contrasting with the Sensex's minor dro...

Read More

View All News